Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Involvement of Jun dimerization protein 2 (JDP2) in the maintenance of Epstein-Barr virus latency.

Murata T, Noda C, Saito S, Kawashima D, Sugimoto A, Isomura H, Kanda T, Yokoyama KK, Tsurumi T.

J Biol Chem. 2011 Jun 24;286(25):22007-16. doi: 10.1074/jbc.M110.199836. Epub 2011 Apr 27.

2.

TORC2, a coactivator of cAMP-response element-binding protein, promotes Epstein-Barr virus reactivation from latency through interaction with viral BZLF1 protein.

Murata T, Sato Y, Nakayama S, Kudoh A, Iwahori S, Isomura H, Tajima M, Hishiki T, Ohshima T, Hijikata M, Shimotohno K, Tsurumi T.

J Biol Chem. 2009 Mar 20;284(12):8033-41. doi: 10.1074/jbc.M808466200. Epub 2009 Jan 21.

3.

Herpes simplex virus type 1 infection activates the Epstein-Barr virus replicative cycle via a CREB-dependent mechanism.

Wu H, Li T, Zeng M, Peng T.

Cell Microbiol. 2012 Apr;14(4):546-59. doi: 10.1111/j.1462-5822.2011.01740.x. Epub 2012 Jan 18.

PMID:
22188237
4.

Contribution of myocyte enhancer factor 2 family transcription factors to BZLF1 expression in Epstein-Barr virus reactivation from latency.

Murata T, Narita Y, Sugimoto A, Kawashima D, Kanda T, Tsurumi T.

J Virol. 2013 Sep;87(18):10148-62. doi: 10.1128/JVI.01002-13. Epub 2013 Jul 10.

5.

Regulation of Epstein-Barr virus reactivation from latency.

Murata T.

Microbiol Immunol. 2014 Jun;58(6):307-17. doi: 10.1111/1348-0421.12155. Review.

6.

The ZIIR element of the Epstein-Barr virus BZLF1 promoter plays a central role in establishment and maintenance of viral latency.

Yu X, McCarthy PJ, Lim HJ, Iempridee T, Kraus RJ, Gorlen DA, Mertz JE.

J Virol. 2011 May;85(10):5081-90. doi: 10.1128/JVI.02615-10. Epub 2011 Mar 9.

7.

Regulation of the BZLF1 promoter of Epstein-Barr virus by second messengers in anti-immunoglobulin-treated B cells.

Daibata M, Speck SH, Mulder C, Sairenji T.

Virology. 1994 Feb;198(2):446-54.

PMID:
8291228
8.

Epigenetic histone modification of Epstein-Barr virus BZLF1 promoter during latency and reactivation in Raji cells.

Murata T, Kondo Y, Sugimoto A, Kawashima D, Saito S, Isomura H, Kanda T, Tsurumi T.

J Virol. 2012 May;86(9):4752-61. doi: 10.1128/JVI.06768-11. Epub 2012 Feb 22.

12.

Switching of EBV cycles between latent and lytic states.

Murata T, Tsurumi T.

Rev Med Virol. 2014 May;24(3):142-53. doi: 10.1002/rmv.1780. Epub 2013 Dec 11. Review.

PMID:
24339346
13.

Either ZEB1 or ZEB2/SIP1 can play a central role in regulating the Epstein-Barr virus latent-lytic switch in a cell-type-specific manner.

Ellis AL, Wang Z, Yu X, Mertz JE.

J Virol. 2010 Jun;84(12):6139-52. doi: 10.1128/JVI.02706-09. Epub 2010 Apr 7.

14.

The chemopreventive compound curcumin is an efficient inhibitor of Epstein-Barr virus BZLF1 transcription in Raji DR-LUC cells.

Hergenhahn M, Soto U, Weninger A, Polack A, Hsu CH, Cheng AL, Rösl F.

Mol Carcinog. 2002 Mar;33(3):137-45.

PMID:
11870879
15.

Identification of a novel element involved in regulation of the lytic switch BZLF1 gene promoter of Epstein-Barr virus.

Kraus RJ, Mirocha SJ, Stephany HM, Puchalski JR, Mertz JE.

J Virol. 2001 Jan;75(2):867-77.

18.
19.

Promoter sequences required for reactivation of Epstein-Barr virus from latency.

Binné UK, Amon W, Farrell PJ.

J Virol. 2002 Oct;76(20):10282-9.

20.

Interplay between PKCδ and Sp1 on histone deacetylase inhibitor-mediated Epstein-Barr virus reactivation.

Tsai PF, Lin SJ, Weng PL, Tsai SC, Lin JH, Chou YC, Tsai CH.

J Virol. 2011 Mar;85(5):2373-85. doi: 10.1128/JVI.01602-10. Epub 2010 Dec 15.

Supplemental Content

Support Center